☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
rare pediatric disease designation
LEXEO Therapeutics' LX2006 Receives the US FDA's Rare Pediatric Disease Designation and Orphan Drug Designation to Treat Friedreic...
July 1, 2021
Taysha Gene Therapies' TSHA-101 Receives the US FDA's Orphan Drug Designation and Rare Pediatric Disease Designation for GM2 Gangl...
August 28, 2020
ProQR's QR-421a Receives FDA's Rare Pediatric Disease Designation for Retinitis Pigmentosa
January 31, 2020
Atsena Therapeutics’ ATSN-201 Gains the US FDA’s Rare Pediatric Disease Designation for Treating Retinoschisis
August 14, 2024
Actio Biosciences’ ABS-0871 Gains Orphan Drug Designation to Treat Charcot-Marie-Tooth Disease 2C
August 9, 2024
META Pharmaceuticals’ META-001-PH Receives the US FDA’s Rare Pediatric Disease Designation to Treat Primary Hyperoxaluria
August 6, 2024
ConSynance Therapeutics’ CSTI-500 Receives the US FDA’s Rare Pediatric Disease Designation to Treat Prader-Willi Syndrome
July 25, 2024
New Drug Designations - April 2024
May 30, 2024
New Drug Designations - March 2024
April 30, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.